ArticleJournal of clinical laboratory analysis2023

Circulating tumor necrosis factor-α, interleukin-1β, and interleukin-17A estimates increased major adverse cardiac event risk in acute myocardial infarction patients.

Jing Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.